Why does cancer cause weight loss?
21 September, 2015An international research team has uncovered the cause of the muscle-wasting disease cachexia in cancer patients. Their study brings hope to the large number of people who suffer from this wasting condition.
Exploring immunology at the Indo-Australian Biotechnology Conference
18 August, 2015The Westmead Millennium Institute for Medical Research will next month host the 11th annual Indo-Australian Biotechnology Conference, providing an opportunity for Australian medical researchers to forge closer links with their Indian counterparts.
Oxford spin-out sold for US$160 million
13 August, 2015Oxford University spin-out company Oxitec, which is commercialising technology to control disease-carrying insects and pests, has been sold to synthetic biology specialist Intrexon Corporation for US$160 million.
Microinjection into plant cells of etiolated seedlings
05 August, 2015 by Tim Kunkel, Albert-Ludwigs-UniversityFor several model systems, microinjection is an established method to introduce DNA into single cells to generate transient and stable transformants. The injection of single cells within plant organs, however, is more difficult.
Novartis flu vaccine business bought by CSL
04 August, 2015CSL has completed its acquisition of the Novartis global influenza vaccine business for a cash consideration of US$275 million. A new subsidiary resulting from the acquisition is set to become the second-largest influenza vaccine business in the US$4 billion global industry.
Rheumatoid arthritis and heart valve disease link
22 July, 2015The overproduction of an inflammatory protein that causes rheumatoid arthritis has also been implicated in the development of heart valve disease.
Creating nanomedicines from antibodies
21 July, 2015A new ARC Linkage grant will assist ongoing development of antibody technology developed by immuno-oncology company Minomic.
The pharmaceutical scientist
14 July, 2015 by Susan WilliamsonProfessor Patrick Sexton, head of the Drug Discovery Biology theme at the Monash Institute of Pharmaceutical Science, reflects on a research career in pharmacology and how working within a large research program that encompasses translational drug discovery, drug delivery and drug development has enriched his team's research.
Stronger stem cells to control inflammation and immune response
07 July, 2015Researchers have discovered a method for culturing stem cells that sees the highly therapeutic cells grow faster and stronger — a breakthrough which is expected to eventually lead to new treatments for transplant patients.
In Vitro Technologies partners with Novus Biologicals in ANZ
02 July, 2015In Vitro Technologies has been announced as the distributor for Novus Biologicals in Australia and New Zealand as of 1 July 2015.
Superbug genome successfully decoded
30 June, 2015Researchers have completed the first large-scale study that uses genomic technology to decode the genes of the bacterium Klebsiella pneumoniae (KP).
Genea Biocells opens facility in USA
26 June, 2015Genea Biocells has announced the expansion of its operations to the United States, in a move described by general manager Dr Uli Schmidt as "the next step to grow Genea Biocells into a world-leading stem cell company".
European Inventor Award goes to Gardasil creators
12 June, 2015The Queensland-based inventors of the Gardasil HPV vaccine have won the Popular Prize category of the 2015 European Inventor Award — a prestigious annual award that acknowledges inventors who have made major contributions towards social, technological and economic progress.
Australian clinical scientist honoured in Copenhagen
10 June, 2015The European Society of Clinical Microbiology and Infectious Diseases has announced University of Queensland Professor Jason Roberts as one of three winners of its 2015 Young Investigator Awards.
Review finds CRCs valuable but in need of improvement
10 June, 2015 by Susan WilliamsonThe Miles Review of the CRC Program has been handed down and all 18 recommendations accepted by the Australian Government.
